Enlivex Therapeutics Ltd. (ENLV)

Last Closing Price: 1.19 (2025-06-24)

Earnings Announcements: Estimated vs Actual

On 2025-05-30, Enlivex Therapeutics Ltd. (ENLV) announced earnings per share of $-0.15 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.16.

The next expected annoucement date for quarterly earnings is 2025-08-29, with an average estimated earnings per share of $-0.16 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-30 2025-03-31 $-0.16 $-0.15
2025-03-31 2024-12-31 -- $-0.23
2024-11-29 2024-09-30 $-0.16 $-0.12
2024-08-30 2024-06-30 $-0.22 $-0.16
2024-06-14 2024-03-31 $-0.25 $-0.22
2024-03-29 2023-12-31 -- $-0.48
2023-11-09 2023-09-30 $-0.32 $-0.32
2023-09-01 2023-06-30 $-0.43 $-0.37
2023-06-16 2023-03-31 $-0.40 $-0.39
2023-03-31 2022-12-31 -- $-0.39
2022-12-05 2022-09-30 $-0.29 $-0.31
2022-08-22 2022-06-30 $-0.45 $-0.54
2022-05-27 2022-03-31 $-0.41 $-0.45
2022-04-29 2021-12-31 -- $-0.26
2021-11-22 2021-09-30 $-0.21 $-0.19
2021-08-09 2021-06-30 $-0.26 $-0.17
2021-06-01 2021-03-31 $-0.21 $-0.19
2021-04-30 2020-12-31 -- $-0.43
2020-10-30 2020-09-30 $-0.18 $-0.16
2020-08-14 2020-06-30 $-0.24 $-0.23
2020-05-18 2020-03-31 $-0.24 $-0.07
2020-04-30 2019-12-31 -- $-0.28
2019-11-14 2019-09-30 -- $-0.23
2019-07-26 2019-06-30 -- $-0.14
2019-05-20 2019-03-31 -- $-0.74
2018-04-23 2017-12-31 -- $-1.36
2017-11-02 2017-09-30 -- $-2.56
2017-08-04 2017-06-30 -- $-4.00
2017-05-26 2017-03-31 $-11.60 $-6.40
2017-02-24 2016-12-31 $-10.80 $-7.60
2016-11-29 2016-09-30 $-10.40 $-11.20
2016-08-25 2016-06-30 $-10.80 $-8.80
2016-05-25 2016-03-31 $-11.60 $12.80
2016-02-23 2015-12-31 $-10.00 $-13.60
2015-11-17 2015-09-30 $-11.60 $-10.00
2015-08-21 2015-06-30 $-11.20 $-10.40
2015-05-19 2015-03-31 $-10.00 $-9.20
2015-02-17 2014-12-31 $-6.40 $-8.80